We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-13.1%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$5B
AUM Growth
-$909M
Cap. Flow
-$36.2M
Cap. Flow %
-0.72%
Top 10 Hldgs %
18.91%
Holding
2,646
New
66
Increased
797
Reduced
791
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Financials 13.9%
3 Healthcare 13.55%
4 Consumer Discretionary 10%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVLA
2576
Palvella Therapeutics
PVLA
$2.23B
-196
Closed -$87.7K
SBT
2577
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
-7,954
Closed -$90K
SYRS
2578
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-926
Closed -$110K
DCPH
2579
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-2,766
Closed -$107K
MRNS
2580
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-3,382
Closed -$135K
DSKE
2581
DELISTED
Daseke, Inc. Common Stock
DSKE
-14,008
Closed -$112K
CURO
2582
DELISTED
CURO Group Holdings Corp.
CURO
-4,145
Closed -$125K
PRTK
2583
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-14,760
Closed -$143K
KDNY
2584
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-4,491
Closed -$165K
USX
2585
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-12,362
Closed -$171K
IVC
2586
DELISTED
Invacare Corporation
IVC
-11,207
Closed -$163K
XELA
2587
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-1
Closed -$117K
TREC
2588
DELISTED
Trecora Resources
TREC
-8,661
Closed -$121K
IIN
2589
DELISTED
IntriCon Corporation
IIN
-2,535
Closed -$142K
ADMS
2590
DELISTED
Adamas Pharmaceuticals
ADMS
-7,606
Closed -$152K
BPY
2591
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-168
Closed -$3.51K
RNET
2592
DELISTED
RigNet, Inc.
RNET
-5,352
Closed -$109K
ARA
2593
DELISTED
American Renal Associates Holdings, Inc
ARA
-4,918
Closed -$106K
AXAS
2594
DELISTED
Abraxas Petroleum Corp
AXAS
-2,226
Closed -$104K
INWK
2595
DELISTED
InnerWorkings, Inc.
INWK
-14,551
Closed -$115K
PSV
2596
DELISTED
Hermitage Offshore Services Ltd.
PSV
0
CVIA
2597
DELISTED
Covia Holdings Corporation Common Stock
CVIA
-10,663
Closed -$95.6K
GNC
2598
DELISTED
GNC Holdings, Inc.
GNC
-24,764
Closed -$103K
INAP
2599
DELISTED
Internap Corporation
INAP
-7,105
Closed -$89.7K
AVEO
2600
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-3,847
Closed -$127K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 Portfolio in Review

As of Q4 2018, Metropolitan Life Insurance Company (MetLife) held 2,646 positions worth $5B, down 15% from $5.91B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 filing shows 66 new, 797 increased, 791 reduced and 99 closed positions. Its largest new stake was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M. The largest sale was Aetna Inc, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $61M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $10.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Aetna Inc in Q4 2018, selling an estimated $10.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5B portfolio in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 99 in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 15% quarter-over-quarter to $5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.